Abordagem actual da gota.
Gout, one of the most prevalent rheumatic diseases in the world, results from deposition of uric acid crystals in several locations, particularly in joints, subcutaneous tissues and kidney. The classical treatments, although effective, are often poorly tolerated or contraindicated. Recently, new dru...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ordem dos Médicos
2011-12-01
|
| Series: | Acta Médica Portuguesa |
| Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/507 |
| _version_ | 1811226437069307904 |
|---|---|
| author | Cláudia Miguel Maria Jesús Mediavilla |
| author_facet | Cláudia Miguel Maria Jesús Mediavilla |
| author_sort | Cláudia Miguel |
| collection | DOAJ |
| description | Gout, one of the most prevalent rheumatic diseases in the world, results from deposition of uric acid crystals in several locations, particularly in joints, subcutaneous tissues and kidney. The classical treatments, although effective, are often poorly tolerated or contraindicated. Recently, new drugs have emerged for the treatment of hyperuricemia and gout, including febuxostat and uricase, which proved to be quite promising. Some drugs already used in other diseases, such as losartan, atorvastatin, fenofibrate and amlodipine also seem to have a role in monitoring the serum uric acid. This article reviews the pathophysiology, clinical management and current therapeutic options for Hyperuricemia and Gout. |
| first_indexed | 2024-04-12T09:25:06Z |
| format | Article |
| id | doaj.art-c4701290161848f39e3d1f121ab968b6 |
| institution | Directory Open Access Journal |
| issn | 0870-399X 1646-0758 |
| language | English |
| last_indexed | 2024-04-12T09:25:06Z |
| publishDate | 2011-12-01 |
| publisher | Ordem dos Médicos |
| record_format | Article |
| series | Acta Médica Portuguesa |
| spelling | doaj.art-c4701290161848f39e3d1f121ab968b62022-12-22T03:38:31ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582011-12-0124510.20344/amp.507Abordagem actual da gota.Cláudia Miguel0Maria Jesús MediavillaInstituto Português de Reumatologia, Lisboa, Portugal.Gout, one of the most prevalent rheumatic diseases in the world, results from deposition of uric acid crystals in several locations, particularly in joints, subcutaneous tissues and kidney. The classical treatments, although effective, are often poorly tolerated or contraindicated. Recently, new drugs have emerged for the treatment of hyperuricemia and gout, including febuxostat and uricase, which proved to be quite promising. Some drugs already used in other diseases, such as losartan, atorvastatin, fenofibrate and amlodipine also seem to have a role in monitoring the serum uric acid. This article reviews the pathophysiology, clinical management and current therapeutic options for Hyperuricemia and Gout.https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/507 |
| spellingShingle | Cláudia Miguel Maria Jesús Mediavilla Abordagem actual da gota. Acta Médica Portuguesa |
| title | Abordagem actual da gota. |
| title_full | Abordagem actual da gota. |
| title_fullStr | Abordagem actual da gota. |
| title_full_unstemmed | Abordagem actual da gota. |
| title_short | Abordagem actual da gota. |
| title_sort | abordagem actual da gota |
| url | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/507 |
| work_keys_str_mv | AT claudiamiguel abordagemactualdagota AT mariajesusmediavilla abordagemactualdagota |